Recent Market Report: Non-Invasive Prenatal Testing (NIPT) Market

Posted by Abhishek Budholiya on 5:20 AM with No comments
 Non-Invasive Prenatal Testing (NIPT) MarketNon-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal sex determination. This report studies the current market scenario and future potential for non-invasive prenatal tests globally. The major NIPTs studied in this report are MaterniT21 PLUS, Harmony, Panorama, verifi, NIFTY, PrenaTest and BambniTest.

Browse Complete report with TOC : http://www.marketresearchreports.biz/analysis-details/noninvasive-prenatal-diagnostics-market-global-industry-size-market-share-trends-analysis-and-forecasts-2012-2018

The report also includes a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global NIPT market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the NIPT market such as Sequenom, Inc., Ariosa Diagnostics, Natera, Inc., Verinata Health, Inc., BGI Health, LifeCodexx and Berry Genomics.

Non-Invasive Prenatal Testing Market, by Test
  • MaterniT21 PLUS
  • verifi
  • Harmony
  • Panorama
Non-Invasive Prenatal Testing Market, by Geography
  • North America
  • Europe
  • Asia-Pacific

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources

Chapter 2 Executive Summary

Chapter 3 Global Non-Invasive Prenatal Testing Market Overview
3.1 Introduction
3.2 Major Chromosomal Aneuploidies and their Incidence Rate
3.2.1 Down Syndrome
3.2.2 Edwards Syndrome

Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 - 2019 (USD Million)
4.1 Overview
4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 – 2019 (USD Million)
4.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 & 2019 (Value %)
4.2 MaterniT21 PLUS
4.2.1 Global MaterniT21 PLUS Test Market Revenue, 2012 – 2019 (USD Million)

TO GET DOWNLOAD FULL REPORT WITH TOC: http://www.marketresearchreports.biz/sample/sample/138993

Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 - 2019 (USD Million)
5.1 Overview
5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 - 2019 (USD Million)
5.1.2 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 & 2019 (Value %)

Chapter 6 Competitive Landscape
6.1 Market Share Analysis, by Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Focus on improving technology in order to increase the accuracy, reduce the duration of result generation and price
7.2 Focus on forming alliances with diagnostic service providers in European and Asia-Pacific countries
7.3 Mergers and acquisitions

Chapter 8 Company Profiles
8.1 Ariosa Diagnostics, Inc.
8.1.1 Company Overview
8.1.2 Product Portfolio
8.1.3 Business Strategies

Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: +1-866-997-4948